The PTEN gene is involved in 10q23 deletions in several types of cancer, including glioma, melanoma, endometrial and prostate carcinomas. The PTEN gene product is a dual-specificity phosphatase with putative tumor suppressor function. Deletions and rearrangements of 10q22-25 have been reported in ϳ5
Cytogenetic and molecular analysis of 6q deletions in burkitt's lymphoma cell lines
✍ Scribed by Nasser Z. Parsa; Asit B. Mukherjee; Dr. R. S. K. Chaganti; Gianluca Gaidano; Robert S. Hauptschein; Riccardo Dalla-Favera; Gilbert Lenoir
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 442 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Although abnormalities of chromosome 6 have frequently been observed in Burkitt's lymphoma (BL), they have 50 far not been defined by modern cytogenetic and molecular methods. By a combination of high‐resolution chromosome banding, fluorescence in situ hybridization (FISH), and loss of heterozygosity (LOH) analysis, we have examined the nature of aberrations affecting chromosome 6 in 7 previously established BL cell lines. All cell lines exhibited the characteristic translocations associated with BL; 5 had t(814)(q24;q32) and 2 had t(8;22)(q24;q11). Three cell lines had deletions of 6q; 3 others had rearrangements affecting 6q, whereas one cell line had apparently normal chromosomes 6. FISH analysis of the three deletions established that they were interstitial. LOH analysis with probes mapped to the 6q26‐27 region confirmed the sub‐telomeric interstitial deletion in cell line BL‐108, which had a del(6)(q23q27). All informative loci mapped to 6q26‐27 (5/7) were deleted in BL‐74, which had no apparent cytogenetic abnormality in chromosome 6, thus documenting a sub‐microscopic deletion. These data define the cytogenetic and molecular limits of 6q deletions in BL and are consistent with our previous demonstration of LOH analysis of the site of a candidate tumor suppressor gene in the 6q25‐27 region. Genes Chrom Cancer 9:13‐18 (1994). ©1994 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Eliminating Epstein‐Barr virus (EBV) genomes from infected cells is an intriguing theoretical strategy in therapy for EBV‐associated malignant diseases. Respective patterns were characterized for hydroxyurea (HU)‐promoted loss of EBV genomes from EBV‐infected epithelioid cell lines deri
It has recently been recognized that unbalanced translocations resulting in the gain of material from 17q are the most common chromosomal changes in neuroblastoma. These rearrangements are associated with established indicators of bad prognosis and poor patient survival. We have used 13 fluorescence
Deletions of the long arm of chromosome 6 (6q) are among the most frequent chromosome aberrations in malignant lymphomas and often occur as secondary changes in addition to typical translocations, such as t(14;18). Using fluorescence in situ hybridization (FISH) with two YAC probes hybridizing to 6q
## Abstract Epstein–Barr virus (EBV) infects more than 90% of the human population and has a potential oncogenic nature. Trichostatin A (TSA) has potent antitumor activity, but its exact mechanism on EBV‐infected cells is unclear. This study examined the effects of TSA on proliferation and apoptosi